|
Volumn 20, Issue 6, 2001, Pages 687-688
|
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
RETEPLASE;
ACUTE HEART INFARCTION;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FIBRINOLYTIC THERAPY;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART REINFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MORTALITY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ST SEGMENT ELEVATION;
STROKE;
TREATMENT OUTCOME;
COMBINED MODALITY THERAPY;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RANDOMIZED CONTROLLED TRIALS;
THROMBOLYTIC THERAPY;
|
EID: 0034876186
PISSN: 08702551
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (5)
|
References (8)
|